(Q34614373)

3 August 2017

1 reference

title

Optimizing the pharmacology of statins: characteristics of rosuvastatin (English)

1 reference

3 August 2017

1 reference

M John Chapman

1

1 reference

3 August 2017

Fergus McTaggart

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Atherosclerosis. Supplements

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

33-6; discussion 36-7

1 reference

Structural mechanism for statin inhibition of HMG-CoA reductase

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900016-2

7 January 2021

10.1016/S1567-5688(01)00016-2

Identifiers

DOI

1 reference

3 August 2017

1 reference